PDF(Pubmed)
Abstract：
BACKGROUND: The psychological well-being of lung cancer patients is critical in-patient care but frequently overlooked.
METHODS: This study, employing a cross-sectional, questionnaire-based design, aimed to elucidate the prevalence of depressive and anxiety symptoms among lung cancer patients and identify associated risk factors. Participants\' demographic, medical history, disease stage, and pathology were systematically collected. Psychological assessment was conducted using the general anxiety disorder-7 (GAD-7), patient health questionnaire-9 (PHQ-9), and hospital anxiety and depression scale (HADS). Statistical analyses were performed using SPSS software (version 25.0).
RESULTS: Out of 294 distributed questionnaires, 247 lung cancer patients were included in the final analysis, with an average completion time of 9.08 min. Notably, 32.4% exhibited depressive symptoms, while 30% displayed signs of anxiety. A significant correlation was found between both depressive and anxiety symptoms and a history of tobacco and alcohol consumption. Specifically, increased nicotine dependence and greater cumulative tobacco use were linked to higher rates of depressive symptoms, whereas cumulative alcohol consumption was associated with increased risks of anxiety symptoms.
CONCLUSIONS: The study affirms the feasibility of GAD-7, PHQ-9, and HADS as screening tools for depressive and anxiety symptoms in lung cancer patients. It further highlights tobacco and alcohol consumption as significant risk factors for poor psychological health in this population.
METHODS: This study, employing a cross-sectional, questionnaire-based design, aimed to elucidate the prevalence of depressive and anxiety symptoms among lung cancer patients and identify associated risk factors. Participants\' demographic, medical history, disease stage, and pathology were systematically collected. Psychological assessment was conducted using the general anxiety disorder-7 (GAD-7), patient health questionnaire-9 (PHQ-9), and hospital anxiety and depression scale (HADS). Statistical analyses were performed using SPSS software (version 25.0).
RESULTS: Out of 294 distributed questionnaires, 247 lung cancer patients were included in the final analysis, with an average completion time of 9.08 min. Notably, 32.4% exhibited depressive symptoms, while 30% displayed signs of anxiety. A significant correlation was found between both depressive and anxiety symptoms and a history of tobacco and alcohol consumption. Specifically, increased nicotine dependence and greater cumulative tobacco use were linked to higher rates of depressive symptoms, whereas cumulative alcohol consumption was associated with increased risks of anxiety symptoms.
CONCLUSIONS: The study affirms the feasibility of GAD-7, PHQ-9, and HADS as screening tools for depressive and anxiety symptoms in lung cancer patients. It further highlights tobacco and alcohol consumption as significant risk factors for poor psychological health in this population.
摘要：
背景：肺癌患者的心理健康是至关重要的住院护理，但经常被忽视。
方法：本研究，采用横截面，基于问卷的设计，旨在阐明肺癌患者中抑郁和焦虑症状的患病率，并确定相关的危险因素。参与者\'人口统计，病史,疾病阶段,系统收集病理。使用一般焦虑症-7（GAD-7）进行心理评估，患者健康问卷-9（PHQ-9），医院焦虑抑郁量表(HADS)。使用SPSS软件(版本25.0)进行统计学分析。
结果：在294份发放的问卷中，247例肺癌患者纳入最终分析，平均完成时间为9.08分钟。值得注意的是,32.4%表现为抑郁症状，而30%的人表现出焦虑的迹象。抑郁和焦虑症状与烟草和酒精消费史之间存在显着相关性。具体来说,增加尼古丁依赖和更多的累积烟草使用与更高的抑郁症状发病率有关，而累积饮酒与焦虑症状风险增加相关.
结论：该研究确认了GAD-7、PHQ-9和HADS作为肺癌患者抑郁和焦虑症状筛查工具的可行性。它进一步强调了烟草和酒精消费是该人群心理健康不良的重要风险因素。
方法：本研究，采用横截面，基于问卷的设计，旨在阐明肺癌患者中抑郁和焦虑症状的患病率，并确定相关的危险因素。参与者\'人口统计，病史,疾病阶段,系统收集病理。使用一般焦虑症-7（GAD-7）进行心理评估，患者健康问卷-9（PHQ-9），医院焦虑抑郁量表(HADS)。使用SPSS软件(版本25.0)进行统计学分析。
结果：在294份发放的问卷中，247例肺癌患者纳入最终分析，平均完成时间为9.08分钟。值得注意的是,32.4%表现为抑郁症状，而30%的人表现出焦虑的迹象。抑郁和焦虑症状与烟草和酒精消费史之间存在显着相关性。具体来说,增加尼古丁依赖和更多的累积烟草使用与更高的抑郁症状发病率有关，而累积饮酒与焦虑症状风险增加相关.
结论：该研究确认了GAD-7、PHQ-9和HADS作为肺癌患者抑郁和焦虑症状筛查工具的可行性。它进一步强调了烟草和酒精消费是该人群心理健康不良的重要风险因素。
